File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Subcutaneous steroid injection as treatment for chalazion: Prospective case series

TitleSubcutaneous steroid injection as treatment for chalazion: Prospective case series
Authors
Issue Date2002
PublisherHong Kong Medical Association. The Journal's web site is located at http://www.hkmj.org/resources/supp.html
Citation
Hong Kong Medical Journal, 2002, v. 8 n. 1, p. 18-20 How to Cite?
AbstractObjective. To study the efficacy of subcutaneous steroid injection in the treatment of chalazion. Design. Prospective consecutive case series. Setting. University teaching hospital, Hong Kong. Patients. Patients with chalazion presenting to the out-patient clinic of the Department of Ophthalmology at the Prince of Wales Hospital from January to June 1998. Main outcome measures. Size of the chalazion after steroid injection treatment. Results. Forty-eight consecutive patients with chalazion were treated with injection of triamcinolone into the subcutaneous tissue around the lesion. In 43 (89.6%) patients, the lesion subsided completely. Twenty-six (54.2%) patients had lesions that subsided with one injection. The size and duration of the chalazion at presentation did not significantly affect the outcome of the treatment. Two patients developed depigmentation of the skin at the site of injection. No other major complications were encountered. Conclusion. Subcutaneous injection of the steroid triamcinolone acetonide appears to be a simple and effective treatment for chalazion. Further comparative clinical trials are indicated.
Persistent Identifierhttp://hdl.handle.net/10722/176381
ISSN
2015 Impact Factor: 0.887
2015 SCImago Journal Rankings: 0.279
References

 

DC FieldValueLanguage
dc.contributor.authorHo, SYen_US
dc.contributor.authorLai, JSMen_US
dc.date.accessioned2012-11-26T09:10:56Z-
dc.date.available2012-11-26T09:10:56Z-
dc.date.issued2002en_US
dc.identifier.citationHong Kong Medical Journal, 2002, v. 8 n. 1, p. 18-20en_US
dc.identifier.issn1024-2708en_US
dc.identifier.urihttp://hdl.handle.net/10722/176381-
dc.description.abstractObjective. To study the efficacy of subcutaneous steroid injection in the treatment of chalazion. Design. Prospective consecutive case series. Setting. University teaching hospital, Hong Kong. Patients. Patients with chalazion presenting to the out-patient clinic of the Department of Ophthalmology at the Prince of Wales Hospital from January to June 1998. Main outcome measures. Size of the chalazion after steroid injection treatment. Results. Forty-eight consecutive patients with chalazion were treated with injection of triamcinolone into the subcutaneous tissue around the lesion. In 43 (89.6%) patients, the lesion subsided completely. Twenty-six (54.2%) patients had lesions that subsided with one injection. The size and duration of the chalazion at presentation did not significantly affect the outcome of the treatment. Two patients developed depigmentation of the skin at the site of injection. No other major complications were encountered. Conclusion. Subcutaneous injection of the steroid triamcinolone acetonide appears to be a simple and effective treatment for chalazion. Further comparative clinical trials are indicated.en_US
dc.languageengen_US
dc.publisherHong Kong Medical Association. The Journal's web site is located at http://www.hkmj.org/resources/supp.htmlen_US
dc.relation.ispartofHong Kong Medical Journalen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshChalazion - Drug Therapyen_US
dc.subject.meshChi-Square Distributionen_US
dc.subject.meshChilden_US
dc.subject.meshChild, Preschoolen_US
dc.subject.meshFemaleen_US
dc.subject.meshGlucocorticoids - Therapeutic Useen_US
dc.subject.meshHumansen_US
dc.subject.meshInfanten_US
dc.subject.meshInjections, Intralesionalen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshProspective Studiesen_US
dc.subject.meshTreatment Outcomeen_US
dc.subject.meshTriamcinolone - Therapeutic Useen_US
dc.titleSubcutaneous steroid injection as treatment for chalazion: Prospective case seriesen_US
dc.typeArticleen_US
dc.identifier.emailLai, JSM: laism@hku.hken_US
dc.identifier.authorityLai, JSM=rp00295en_US
dc.description.naturelink_to_OA_fulltexten_US
dc.identifier.pmid11861988-
dc.identifier.scopuseid_2-s2.0-0036177941en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0036177941&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume8en_US
dc.identifier.issue1en_US
dc.identifier.spage18en_US
dc.identifier.epage20en_US
dc.publisher.placeHong Kongen_US
dc.identifier.scopusauthoridHo, SY=36839067000en_US
dc.identifier.scopusauthoridLai, JSM=7401939748en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats